UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes

Annals of internal medicine, 2016-04, Vol.164 (8), p.542

2016

Volltextzugriff (PDF)

User's guide to mechanism of action and clinical use of GLP-1 receptor agonists

Postgraduate medicine, 2015-01, Vol.127 (8), p.818-826

2015

Volltextzugriff (PDF)

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes

Annals of internal medicine, 2016-04, Vol.164 (8), p.542

2016

Volltextzugriff (PDF)

Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies

Clinical diabetes, 2016-04, Vol.34 (2), p.81-85

Shaefer, Jr, Charles F

2016

Volltextzugriff (PDF)

Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus

Diabetes therapy, 2017-02, Vol.8 (1), p.33-53

2017

Volltextzugriff (PDF)

Commentary: Exenatide QW: A New Treatment Option for Type 2 Diabetes Offering Ease of Use, Improved Efficacy, and Reduced Side Effects

Clinical diabetes, 2012-06, Vol.30 (3), p.92-94

Shaefer, Charles F., Jr

2012

Volltextzugriff (PDF)

Weight Change in Patients with Type 2 Diabetes Starting Basal Insulin Therapy: Correlates and Impact on Outcomes

Postgraduate medicine, 2014-10, Vol.126 (6), p.93-104

2014

Volltextzugriff (PDF)

Using a Quantitative Measure of Diabetes Risk in Clinical Practice to Target and Maximize Diabetes Prevention Interventions

Clinical diabetes, 2013-03, Vol.31 (2), p.82-89

2013

Volltextzugriff (PDF)

The Good Old Days Were Not So Good for Inpatient Care

Insulin, 2007, Vol.2 (1), p.2-3

Shaefer, Charles F

2007

Volltextzugriff (PDF)

Insulin and Type 2 Diabetes Mellitus Treatment Today: Are We at a Tipping Point?

Insulin, 2007-07, Vol.2 (3), p.106-108

Shaefer, Jr, Charles F.

2007

Volltextzugriff (PDF)

In search of the holy grail? The quest to reduce macrovascular disease in type 2 diabetes mellitus

Insulin, 2010, Vol.5 (1), p.2-6

Shaefer, Charles F.

2010

Volltextzugriff (PDF)

The pen is mightier than the sword

Insulin, 2009-07, Vol.4 (3), p.132-135

Shaefer, Charles F.

2009

Volltextzugriff (PDF)

Shopping for basal insulin on the coffee aisle: Lots of choices for lots of tastes

Insulin, 2008-07, Vol.3 (3), p.146-149

Shaefer, Charles F.

2008

Volltextzugriff (PDF)

Implications of the ADA/EASD consensus algorithm for treatment of type 2 diabetes mellitus for primary care practitioners: Four pivotal points

Insulin, 2008-04, Vol.3, p.126-131

Shaefer, Charles F.

2008

Volltextzugriff (PDF)

Sunshine on a rainy day: Good news for diabetes

Insulin, 2008-04, Vol.3 (2), p.56-58

Shaefer, Charles F.

2008

Volltextzugriff (PDF)

Patient and Physician Barriers to Instituting Insulin Therapy: A Case-Based Overview

Insulin, 2007-11, Vol.2, p.S41-S46

Shaefer, Charles F.

2007

Volltextzugriff (PDF)

Afloat in a rising sea of type 2 diabetes: Looking for lighthouses in the 4-T trial

Insulin, 2008, Vol.3 (1), p.2-4

Shaefer, Charles F.

2008

Volltextzugriff (PDF)

Is diabetes mellitus ready for the “Do It Yourself” approach?

Insulin, 2007-10, Vol.2 (4), p.154-156

Shaefer, Charles F.

2007

Volltextzugriff (PDF)

Physicians' Corner Advancing Change—Perspectives on Postprandial Glycemia

Insulin, 2007-04, Vol.2 (2), p.50-51

Shaefer, Charles F.

2007

Volltextzugriff (PDF)

The evolving science and practice of insulin therapy

Insulin, 2007-03, Vol.2, p.S1-S3

Shaefer, Charles F.

2007

Volltextzugriff (PDF)

Clinical inertia: Overcoming a major barrier to diabetes management

Insulin, 2006-04, Vol.1 (2), p.61-64

Shaefer, Charles F.

2006

Volltextzugriff (PDF)

Melioidosis: Recrudescence with a Strain Resistant to Multiple Antimicrobials 1

The American review of respiratory disease, 1983-07, Vol.128 (1), p.173-175

1983

Volltextzugriff (PDF)

Pharmacokinetics of tacrolimus in liver transplant patients

Clinical pharmacology and therapeutics, 1995-03, Vol.57 (3), p.281-290

1995

Volltextzugriff (PDF)

Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/abacavir regimen in underrepresented HIV-infected patients

Journal of acquired immune deficiency syndromes (1999), 2003-10, Vol.34 (2), p.174-183

2003

Volltextzugriff (PDF)

Twice-Daily Trizivir versus Combivir-Abacavir in Antiretroviral-Experienced Adults with Human Immunodeficiency Virus-1 Infection: A Formulation-Switch Trial

Pharmacotherapy, 2003-11, Vol.23 (11), p.1432-1440

2003

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(25)
Bücher
(1)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(7)
Science & Technology
(7)
Diabetes
(6)
Humans
(6)
Adult
(4)
Adolescent
(3)
Biological And Medical Sciences
(3)
Drug Therapy
(3)
Female
(3)
General & Internal Medicine
(3)
Male
(3)
Medical Sciences
(3)
Medicine, General & Internal
(3)
Middle Aged
(3)
Type 2 Diabetes
(3)
Type 2 Diabetes Mellitus
(3)
Anti-Hiv Agents - Administration & Dosage
(2)
Clinical Inertia
(2)
Clinical Medicine
(2)
Diabetes Mellitus, Type 2 - Drug Therapy
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes

User's guide to mechanism of action and clinical use of GLP-1 receptor agonists

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes

Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies

Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus

Commentary: Exenatide QW: A New Treatment Option for Type 2 Diabetes Offering Ease of Use, Improved Efficacy, and Reduced Side Effects

Weight Change in Patients with Type 2 Diabetes Starting Basal Insulin Therapy: Correlates and Impact on Outcomes

Using a Quantitative Measure of Diabetes Risk in Clinical Practice to Target and Maximize Diabetes Prevention Interventions

The Good Old Days Were Not So Good for Inpatient Care

Insulin and Type 2 Diabetes Mellitus Treatment Today: Are We at a Tipping Point?

In search of the holy grail? The quest to reduce macrovascular disease in type 2 diabetes mellitus

The pen is mightier than the sword

Shopping for basal insulin on the coffee aisle: Lots of choices for lots of tastes

Implications of the ADA/EASD consensus algorithm for treatment of type 2 diabetes mellitus for primary care practitioners: Four pivotal points

Sunshine on a rainy day: Good news for diabetes

Patient and Physician Barriers to Instituting Insulin Therapy: A Case-Based Overview

Afloat in a rising sea of type 2 diabetes: Looking for lighthouses in the 4-T trial

Is diabetes mellitus ready for the “Do It Yourself” approach?

Physicians' Corner Advancing Change—Perspectives on Postprandial Glycemia

The evolving science and practice of insulin therapy

Clinical inertia: Overcoming a major barrier to diabetes management

Melioidosis: Recrudescence with a Strain Resistant to Multiple Antimicrobials 1

Pharmacokinetics of tacrolimus in liver transplant patients

Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/abacavir regimen in underrepresented HIV-infected patients

Twice-Daily Trizivir versus Combivir-Abacavir in Antiretroviral-Experienced Adults with Human Immunodeficiency Virus-1 Infection: A Formulation-Switch Trial

Suchergebnisse filtern